Cancer cells and CSCs often display constitutively activated NF-κB expression that promotes levels of apoptosis inhibitory proteins and drug-resistant proteins, resulting in enhanced survival and resistance to therapies in cancer cells[134-137]. The gene discussed is NFKB1; the disease is cancer.